"Sit down before fact as a little child, be prepared to give up every conceived notion, follow humbly wherever, whatever abysses nature leads, or you will learn nothing" Thomas H. Huxley, letter to C. Kingsley, September 20, 1863 This conference commemorates, almost to the day, the 45 th anniversary of the discovery of the Na + /Ca 2+ exchanger (NCX). The discovery was serendipitous, as is so often the case with scientific breakthroughs. Indeed, that is what is so fascinating and romantic about scientific research. I will describe the discovery of NCX, but will begin by explaining how I got there, and will then discuss how the discovery altered my career path.
For the love of physiology
I was introduced to cell physiology by Howard Schneiderman, a distinguished insect physiologist and developmental biologist, during my undergraduate days at Cornell University. I was interested in neurophysiology and the mind-brain problem, but came under the spell of Daniel Tosteson when I was a medical student at Washington University in St. Louis. Dan convinced me to work on the Na + ,K + -ATPase ('sodium pump'), which had just been discovered (Skou, 1957) . I spent a year-and-a-half in Dan's lab studying the red blood cell cardiotonic steroid-sensitive Na + pump. In 1963, after completing medical school and an internship at Boston City Hospital, I was offered a naval commission to work at the US Naval Medical Research Institute in Bethesda, MD (much better than a tour in Vietnam!). Thus, I returned to neurophysiology and, under David Goldman (of the Goldman-Hodgkin Katz equation), I studied the effects of divalent cations and anesthetics on lobster nerve conduction (Blaustein and Goldman, 1966; Blaustein, 1968) . I also was fortunate to spend a few weeks at Woods Hole with John Moore and Toshio Narahashi working on tetrodotoxin's action on squid axons (Moore et al., 1967) . 
"All hands to the pump"
My expectation was to study squid axon electrophysiology, but Peter Baker, Alan's junior associate, a lecturer at Emmanuel College, Cambridge, took a mini-sabbatical that Fall, and he wanted all Plymouth squid researchers to work on the Na + pump. I was paired up with Rick Steinhardt, Richard Keynes' postdoctoral fellow, and we were tasked with studying the activation of the Na + pump by external cations. Richard came to Plymouth at the end of September; he showed us how to dissect squid axons (not knowing of my prior experience) and how to measure 22 Na + efflux after injecting the giant axons (0.8-1.2 mm diameter) with a microsyringe that he and Alan designed (Hodgkin and Keynes, 1956 Another great day! When I wrote up the results for publication, Alan was reluctant to include the proposed explanation for the cardiotonic action of cardiac glycosides. Therefore, while
Alan was on a lecture tour in Eastern Europe, Peter Baker and I contrived to submit the manuscript, including the cardiotonic steroid hypothesis (Baker et al., 1969) . [Note: J Physiol authorship was alphabetical in those days; there was no jockeying for "first" or "senior" authorship.] Our explanation for the cardiotonic steroid effect was later verified with Ca 2+ measurements (Wier and Hess, 1984; Altamirano et al., 2006) , NCX-knockout mice (Reuter et al., 2002) and NCX blockers (Tanaka et al., 2007) .
NCX on the Continent
At the very same time that we were performing these experiments, (Reuter and Seitz, 1968) . He knew what he was looking for; we were simply lucky, albeit prepared to recognize it when we saw it! As Louis Pasteur put it, "le hazard ne favorise que les esprits prepares."
Harald and I first met at the International Physiology Congress in Washington, DC, in August, 1968. I had just returned from England, and was then heading to St.
Louis to take a faculty position in the Department of Physiology and Biophysics at Washington University. It was a very amicable meeting that soon led to extremely beneficial consequences. Before describing those consequences, however, I should mention some other fallout from our Cambridge years. showed that synaptosomes do reseal, and that they function like intact terminals. They have functional ion transport mechanisms, including Na + pumps and NCX, and they generate ion gradients and membrane potentials (Blaustein and Wiesmann, 1970; Blaustein and Goldring, 1975; Fontana et al., 1995) . Synaptosomes can be triggered to release neurotransmitters and to recycle synaptic vesicle membranes (Fried and Blaustein, 1976; Drapeau and Blaustein, 1983) , and they sequester Ca 2+ in the endoplasmic reticulum (Kendrick et al., 1977) . We discovered voltage-gated Ca 2+ channels in synaptosomes that were resistant to dihydropyridines (Nachshen and Blaustein, 1979) ; this was the first evidence for N, P and Q type Ca 2+ channels (Catterall, 1998; Cao and Tsien, 2010 ) that play such an important role in brain physiology. We also used synaptosomes as an assay for the identification of a number of novel Na + and K + channel inhibitors (Krueger et al., 1980; Blaustein et al., 1991) . In all, we published more than 65 articles on synaptosomes, including 6 in Nature or
PNAS.
In an extension of the synaptosome studies, we are currently testing the NCX- Figure 2B ).
In a manuscript describing these results, we suggested that NCX helps to regulate vascular tone. We also postulated a close approximation between the plasma membrane (PM) NCX and the sarcoplasmic reticulum; this idea foreshadowed the "buffer-barrier" hypothesis (van Breemen et al., 1986; van Breemen et al., 1995) and the "PLasmERosome" model (Blaustein et al., 1998; Arnon et al., 2000b) (Reuter et al., 1973) ; the article has been cited ~300 times.
This novel idea that NCX is functionally important in vascular smooth muscle was, at first, ignored, or even disparaged (Somlyo et al., 1986; Murphy, 1988) . Views about this concept slowly began to change more than two decades after its discovery (Murphy, 1993; Somlyo and Somlyo, 1994) , once the NCX was cloned (Nicoll et al., 1990 ) and could be readily identified by immunocytochemistry and immunoblotting (Vemuri et al., 1990; Blaustein et al., 1992; Juhaszova et al., 1994) .
Tragically, Mani Matter was killed in an auto accident in 1972. Therefore, we were most fortunate to have spent time in Bern in 1971. Mani had become a Swiss folkhero because, as an avocation, he founded the Bernese Troubadors, who wrote and sang humorous and satirical songs in Swiss-German dialect that are still popular today.
PLasmERosomes: a structural basis for functional coupling of transport proteins
The NCX, like many other Na + -coupled transporters, is driven by the Na + electrochemical gradient across the PM (Blaustein and Lederer, 1999) . Nevertheless, we did not anticipate that the NCX would be co-localized with certain other transporters in PM microdomains adjacent to 'junctional' sarcoplasmic or endoplasmic reticulum (jS/ER) in a variety of cell types including neurons, glia and arterial myocytes (Juhaszova and Blaustein, 1997b) . In fact, we were somewhat astonished (but shouldn't have been) that the NCX was confined to the PM microdomains that also contained the Na + pumps with a high ouabain affinity catalytic subunit (α2 or α3, depending upon cell type) (Juhaszova and Blaustein, 1997a) . Moreover, both immunocytochemical and functional studies indicated that the much more prevalent Na + pumps with an α1 catalytic subunit that, in rodents, has low ouabain affinity, were apparently excluded from these microdomains Song et al., 2006) .
Another mechanism that extrudes Ca 2+ from most types of cells, the PM Ca
2+
-ATPase (Ca 2+ pump) may be excluded from these PM microdomains (Lencesova et al., 2004) .
Some other Na + and Ca 2+ transporters also co-localize to these microdomains, notably TRPC proteins that are components of receptor-and store-operated channels (ROCs and SOCs, respectively) (Golovina, 2005; Lee et al., 2006; Zulian et al., 2010a) .
Many ROCs and SOCs are relatively non-selective cation channels, permeable to both Na + and Ca 2+ (Arnon et al., 2000a; Owsianik et al., 2006) .
These findings provided a structural basis for the observations that the high ouabain affinity Na + pumps, NCX, ROCs and SOCs, and the adjacent jS/ER function cooperatively to regulate Ca 2+ signaling in a variety of cell types (Arnon et al., 2000a, b; Eder et al., 2005; Poburko et al., 2007) . I called this PM microdomain-jS/ER complex, the "PLasmERosome" (Figure 3 ). PLasmERosomes appear to be widely distributed, (phosphatidylinositol bis-phosphate) and calmodulin. Not surprisingly, then, these mechanisms may also play prominent roles in pathophysiological processes (Blaustein, 1977) , as discussed in the example below.
Linkage to hypertension and other heretical concepts
I learned from Alan Hodgkin that, if you perform careful, controlled experiments, you should be very confident about your own data. So, ignoring the naysayers, I continued to ponder the role of NCX in vascular smooth muscle, and even began to think that it might play a role in hypertension (Blaustein, 1974) . This led me to propose a naïve, but useful hypothesis about the roles of an hypothetical endogenous cardiotonic steroid, its Na + pump receptor, and NCX, in the pathogenesis of salt-dependent hypertension (Blaustein, 1977) . That was before NCX and the Na + pump were cloned and their isoforms discovered; and, of course, the endogenous cardiotonic steroid was then just a figment of our imagination.
Despite the previously mentioned skepticism of vascular biologists, however, this hypertension hypothesis aroused great interest in the idea of an endogenous ligand for the Na + pump ouabain binding site. In particular, it excited one young man, John
Hamlyn, who was a pre-teenager in Plymouth, England, when we discovered the NCX there. John came to my laboratory in 1980, as a post-doctoral fellow, with the idea of trying to purify this hypothetical agent. Ignoring the enormous difficulties, the fierce competition, and the repeated funding rejections from NIH, our team (John and our colleagues at the Upjohn Company) plunged ahead. In 1991, we purified from two tons of human plasma, and identified, by mass spectroscopy, an endogenous compound that, astonishingly, is indistinguishable from plant ouabain, i.e., "endogenous ouabain"
or EO (Hamlyn et al., 1991) . That paper, too, was rejected by Nature: one reviewer had a "gut feeling" that our result was an artifact, although another reviewer offered to write a "News and Views" article about the discovery. The Nature editor, John Maddox, had just taken the heat for publishing articles on "cold fusion" and "infinite dilution"; he apparently didn't want to take a chance on being burned once more. Fortunately, our friend, Joseph Hoffman, a Na + pump expert, agreed to communicate the manuscript to
PNAS.
Again, many colleagues were skeptical (and some still are), even though the identification of EO was replicated in bovine adrenal and hypothalamic samples by three distinguished groups (Tamura et al., 1994; Schneider et al., 1998; Kawamura et al., 1999) . Nevertheless, our Upjohn co-workers, who performed the original mass spectrometry, convinced us of the correctness of the result. Although the EO biosynthetic pathway has not yet been elucidated (funding bodies are not interested in such mundane studies), John Hamlyn and colleagues demonstrated net synthesis of EO by primary cultured bovine adrenocortical cells (Laredo et al., 1994) . Furthermore, plasma EO levels are very low in adrenalectomized rodents (Hamlyn et al., 1991) and in humans with adrenocortical insufficiency (Sophocleous et al., 2003) .
Ideas about the involvement of EO in the pathogenesis of some forms of hypertension have come a long way since my first, rather simplistic (but perhaps not so far-fetched) thoughts on the subject (Blaustein, 1977) . Recent work is summarized to two reviews (Blaustein and Hamlyn, 2010; Blaustein et al., 2011) .
NCX: a key player in the pathogenesis of hypertension?
I have already alluded to the central role of NCX in Ca 2+ signaling that results from its co-localization with certain (ouabain-sensitive) Na + pumps and ROCs and SOCs in PM microdomains at PM-S/ER junctions (PLasmERosomes). This fit with the simplistic notion that, if circulating EO levels are elevated in patients with hypertension (Rossi et al., 1995) , we would expect the PLasmERosome mechanisms to amplify the Ca 2+ signals. In fact, this is precisely what we observed in isolated, pressurized rodent small arteries: Ca 2+ signals and myogenic constriction were augmented by ouabain with an EC 50 of ~1 nM (Zhang et al., 2005) . Could this account for the increased peripheral vascular resistance and elevation of blood pressure, as I initially proposed (Blaustein, 1977) ?
Alas, life is not so simple! (A good thing, because that's what keeps us scientists in business.) As my colleague, Vera Golovina discovered, the situation in hypertension is much more complex. She and her associates were studying arterial smooth muscle acutely isolated from rats in which hypertension was induced by prolonged subcutaneous infusion of ouabain ("ouabain hypertension"). They found that NCX1 (the vascular isoform) and TRPC6 protein (a component of ROCs) were greatly overexpressed in the myocytes, and that this was reflected in augmented Ca 2+ signaling (Pulina et al., 2010a) . The effects were not due to the elevation of blood pressure: both the protein up-regulation and the augmented Ca 2+ signaling were also induced in primary cultured normal rat arterial myocytes incubated with 100 nM ouabain for 72-96
hr.
[In an important twist, digoxin did not up-regulate NCX1 or TRPC6 expression and, unlike ouabain, it does not induce hypertension in rats (Manunta et al., 2000) -but that's another, as yet incomplete, story.]
Vera and her colleagues also found that NCX1 and TRPC6 were both markedly up-regulated in arterial myocytes from Dahl salt-sensitive rats fed a high salt diet to induce hypertension (Table 2) , and in myocytes from Milan hypertensive rats, but not the normotensive strain . In fact, arterial myocyte NCX1 and either TRPC6 or TRPC3 (another component of ROCs) are up-regulated in all models of hypertension that have been tested to date (Table 2 ). An editorial commentary (Giachini and Tostes, 2010) (Somlyo et al., 1986) . The up-regulation of NCX1
and TRPC6 expression may, in fact, be a key mechanism underlying the phenomenon of "whole body autoregulation" (Guyton, 1989) that sustains the increased peripheral vascular resistance and elevated BP in hypertension.
This, of course, is not the end of the story, but just the beginning of the next chapter. The fun in research is that every new discovery leads to new questions. In this case, we must now ask: "What is the mechanism by which ouabain up-regulates NCX1 and TRPC6 expression?" The up-regulation appears to be mediated by a novel activity of Na + pumps first elucidated by Zi-Jian Xie, namely ouabain-induced activation of protein kinase signaling cascades (Xie and Askari, 2002; Liu et al., 2007; Liu and Xie, 2010; Liu et al., 2011 n is the number of axons in each group., *Li sea water contained 460 mM LiCl in place of NaCl; dextrose sea water contained 720 mM dextrose in place of 460 mM NaCl. In K-free ("0K") sea waters, the 10 mM KCl was replaced by 10 mM NaCl or LiCl, or 20 mM dextrose. Because neither replacement of external K + nor addition of 10 -5 M ouabain affected the Ca 2+ influx, the 0K and ouabain treatment data were not separated. Zulian et al., 2010b) 2 DOCA-salt* ND** ↑ (Bae et al., 2007) 3 Milan hypertension* (vs Milan NT)*** ↑ ↑ 4 SHR (vs WKY)*** ↑ ↑ (Taniguchi et al., 2004; Liu et al., 2009) (Yu et al., 2004; Zhang et al., 2007a; Zhang et al., 2007b) *Hypertension associated with elevated plasma ouabain levels. **Not determined. ***Abbreviations: NT, normotensive control; SHR, spontaneously hypertensive rat; WKY, WistarKyoto normotensive control for SHR; NCX1 SMTg/Tg , smooth muscle-specific NCX1 knockout mouse (Zhang et al., 2010) .
